Free Trial

Marsh & McLennan Companies, Inc. $MRSH Shares Purchased by Vontobel Holding Ltd.

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Vontobel Holding increased its Marsh McLennan stake by 547.3% in the third quarter, purchasing 250,408 additional shares to own 296,160 shares valued at approximately $50.6 million. Institutional investors and hedge funds collectively own 87.99% of the stock.
  • Third-quarter results exceeded expectations: adjusted EPS was $2.03 versus the $1.96 consensus, while revenue rose 8.1% year over year to $6.86 billion. Management highlighted underlying growth, cost pressures, artificial intelligence initiatives and continued execution.
  • Market sentiment remains mixed. The stock has a consensus “Hold” rating with a $203.60 price target; some analysts raised targets after the earnings beat, while others lowered theirs. Meanwhile, insiders sold $3.6 million of shares over the past three months, and the company declared a $0.99 quarterly dividend.
  • Five stocks to consider instead of Marsh & McLennan Companies.

Vontobel Holding Ltd. grew its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) by 547.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 296,160 shares of the financial services provider's stock after buying an additional 250,408 shares during the period. Vontobel Holding Ltd. owned 0.06% of Marsh & McLennan Companies worth $50,563,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in MRSH. Continuum Advisory LLC raised its stake in Marsh & McLennan Companies by 5.3% in the 1st quarter. Continuum Advisory LLC now owns 1,452 shares of the financial services provider's stock valued at $252,000 after purchasing an additional 73 shares during the last quarter. Clearstead Trust LLC boosted its stake in shares of Marsh & McLennan Companies by 12.6% during the 1st quarter. Clearstead Trust LLC now owns 668 shares of the financial services provider's stock worth $116,000 after purchasing an additional 75 shares during the last quarter. Columbia Bank boosted its stake in shares of Marsh & McLennan Companies by 5.1% during the 1st quarter. Columbia Bank now owns 1,736 shares of the financial services provider's stock worth $301,000 after purchasing an additional 85 shares during the last quarter. Capital Analysts LLC boosted its stake in shares of Marsh & McLennan Companies by 37.4% during the 2nd quarter. Capital Analysts LLC now owns 312 shares of the financial services provider's stock worth $52,000 after purchasing an additional 85 shares during the last quarter. Finally, KERR FINANCIAL PLANNING Corp grew its holdings in shares of Marsh & McLennan Companies by 26.8% during the second quarter. KERR FINANCIAL PLANNING Corp now owns 454 shares of the financial services provider's stock worth $76,000 after buying an additional 96 shares in the last quarter. 87.99% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Marsh & McLennan Companies

In other news, insider Martin South sold 7,100 shares of the business's stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the completion of the sale, the insider owned 16,632 shares in the company, valued at approximately $3,159,913.68. The trade was a 29.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Paul Beswick sold 713 shares of the stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total transaction of $141,174.00. Following the sale, the senior vice president directly owned 16,376 shares of the company's stock, valued at approximately $3,242,448. This trade represents a 4.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 19,813 shares of company stock worth $3,597,903 in the last three months. 0.38% of the stock is currently owned by company insiders.

Key Headlines Impacting Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

  • Positive Sentiment: Q3 earnings and revenue exceeded expectations. Marsh reported adjusted EPS of $2.03, above the $1.96 consensus, while revenue reached $6.86 billion, an 8.1% year-over-year increase. Growth in Consulting and Risk and Insurance Services helped offset higher operating expenses. Marsh Reports Third Quarter 2026 Results
  • Positive Sentiment: Management highlighted continued growth and execution. CEO John Doyle cited 5% underlying revenue growth, double-digit EPS growth, progress on the Thrive program and completion of the company’s brand transition. The earnings call also emphasized artificial intelligence initiatives and a new resilience coalition focused on rising global business risks. Marsh & McLennan Earnings Call Highlights Growth, AI Focus
  • Positive Sentiment: Analysts raised their valuation targets. Citigroup increased its target from $200 to $203, while Wells Fargo raised its target from $183 to $197. Both firms retained neutral or equal-weight ratings, suggesting improved expectations but limited conviction for significant outperformance.
  • Neutral Sentiment: Analyst opinion remains cautious. RBC Capital maintained its hold rating, and the latest targets remain close to the stock’s recent trading range. This indicates that the earnings beat has improved estimates without substantially changing the broader valuation debate. RBC Capital Maintains Hold Rating
  • Negative Sentiment: Challenging operating conditions and higher costs remain risks. Commentary indicates that the difficult operating environment may persist, while rising expenses could pressure margins and reduce the benefit of revenue growth. Challenging Operating Environment Likely to Persist

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Morgan Stanley reduced their price objective on shares of Marsh & McLennan Companies from $200.00 to $180.00 and set an "equal weight" rating on the stock in a research note on Tuesday, October 6th. UBS Group lifted their target price on shares of Marsh & McLennan Companies from $216.00 to $222.00 and gave the stock a "buy" rating in a research note on Tuesday, October 6th. Evercore cut their price target on Marsh & McLennan Companies from $234.00 to $224.00 in a report on Thursday, October 8th. Weiss Ratings upgraded Marsh & McLennan Companies from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, August 7th. Finally, BMO Capital Markets decreased their price objective on Marsh & McLennan Companies from $203.00 to $179.00 and set a "market perform" rating on the stock in a report on Thursday, October 1st. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, twelve have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $203.60.

View Our Latest Stock Report on Marsh & McLennan Companies

Marsh & McLennan Companies Stock Performance

Marsh & McLennan Companies stock traded up $2.11 during trading on Friday, reaching $188.65. The company had a trading volume of 2,765,779 shares, compared to its average volume of 3,092,105. Marsh & McLennan Companies, Inc. has a 12-month low of $156.60 and a 12-month high of $198.49. The company has a quick ratio of 1.14, a current ratio of 1.09 and a debt-to-equity ratio of 1.27. The business's 50 day moving average price is $181.17. The stock has a market capitalization of $90.03 billion, a price-to-earnings ratio of 22.57, a price-to-earnings-growth ratio of 2.59 and a beta of 0.59.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings data on Thursday, October 15th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.07. The company had revenue of $6.86 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. Marsh & McLennan Companies's revenue was up 8.1% on a year-over-year basis. As a group, research analysts expect that Marsh & McLennan Companies, Inc. will post 10.44 earnings per share for the current year.

Marsh & McLennan Companies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.99 per share. The ex-dividend date is Thursday, October 1st. This represents a $3.96 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies's dividend payout ratio is currently 48.41%.

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Companies, now operating under the name Marsh McLennan, is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through four principal businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman.

Marsh is an insurance brokerage and risk adviser that helps clients identify, manage and transfer risk. Guy Carpenter provides reinsurance brokerage and advisory services to insurance companies.

Recommended Stories

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines